A study published in The Lancet Oncology establishes for the first time that artificial intelligence can process medical images to extract biological and clinical information.
By designing an algorithm and developing it to analyse CT scan images, medical researchers at Gustave Roussy, CentraleSupélec, Inserm, Paris-Sud University and TheraPanacea (spin-off from CentraleSupélec specialising in artificial intelligence in oncology-radiotherapy and precision medicine) have created a so-called radiomic signature. This signature defines the level of lymphocyte infiltration of a tumour and provides a predictive score for the efficacy of immunotherapy in the patient.
In the future, physicians might thus be able to use imaging to identify biological phenomena in a tumour located in any part of the body without having to perform a biopsy.
Up to now, no marker can accurately identify those patients who will respond to anti-PD-1/PD-L1 immunotherapy in a situation where only 15 to 30% of patients do respond to such treatment. It is known that the richer the tumour environment is immunologically (presence of lymphocytes) the greater the chance that immunotherapy will be effective, so the researchers have tried to characterise this environment using imaging and correlate this with the patients’ clinical response. Such is the objective of the radiomic signature designed and validated in the study published in The Lancet Oncology.
In this retrospective study, the radiomic signature was captured, developed and validated in 500 patients with solid tumours (all sites) from four independent cohorts. It was validated genomically, histologically and clinically, making it particularly robust.
Using an approach based on machine learning, the team first taught the algorithm to use relevant information extracted from CT scans of patients participating in the MOSCATO* study , which also held tumor genome data. Thus, based solely on images, the algorithm learned to predict what the genome might have revealed about the tumour immune infiltrate, in particular with respect to the presence of cytotoxic T-lymphocytes (CD8) in the tumour, and it established a radiomic signature.
This signature was tested and validated in other cohorts including that of TCGA (The Cancer Genome Atlas) thus showing that imaging could predict a biological phenomenon, providing an estimation of the degree of immune infiltration of a tumour.
Then, to test the applicability of this signature in a real situation and correlate it to the efficacy of immunotherapy, it was evaluated using CT scans performed before the start of treatment in patients participating in 5 phase I trials of anti-PD-1/PD-L1 immunotherapy. It was found that the patients in whom immunotherapy was effective at 3 and 6 months had higher radiomic scores as did those with better overall survival.
The next clinical study will assess the signature both retrospectively and prospectively, will use larger numbers of patients and will stratify them according to cancer type in order to refine the signature.
This will also employ more sophisticated automatic learning and artificial intelligence algorithms to predict patient response to immunotherapy. To that end, the researchers are intending to integrate data from imaging, molecular biology and tissue analysis. This is the objective of the collaboration between Gustave Roussy, Inserm, Université Paris-Sud, CentraleSupélec and TheraPanacea to identify those patients who are the most likely to respond to treatment, thus improving the efficacy/cost ratio of the treatment.
The Latest on: Artificial intelligence
via Google News
The Latest on: Artificial intelligence
- COMMENTARY: The infrastructures that support a future of artificial intelligenceon January 25, 2021 at 8:24 am
Through the lens of the responsible innovation in health research program at the Université de Montréal, we critically examine what lies beyond our immediate experiences of AI.
- Five ways artificial intelligence can help space explorationon January 25, 2021 at 6:43 am
From designing missions to clearing Earth’s orbit of junk, here are a few ways artificial intelligence can help us venture further in space. Do you remember Tars and Case, the assistant robots from ...
- How artificial intelligence will change workon January 25, 2021 at 6:39 am
MIT Professor Thomas Malone, Professor Daniela Rus, and Robert Laubacher collaborated on "Artificial Intelligence and the Future of Work," a brief that provides ...
- Healthcare Artificial Intelligence Market Trends Global Industry Analysis, Top Manufacturers, Growth, Opportunities & Forecast to 2026on January 25, 2021 at 6:37 am
Jan (Market Insight Reports) -- Selbyville, Delaware, Market Study Report LLC recently added a new title on 2020-2026 Global Healthcare ...
- US Leading Race In Artificial Intelligence, China Rising: Surveyon January 25, 2021 at 6:17 am
The United States is leading rivals in development and use of artificial intelligence while China is rising quickly and the European Union is lagging, a research report showed Monday. The study by the ...
- DRDO Online Courses 2021: DIAT offers Artificial Intelligence, Cyber Security courses on diat.ac.in-on January 25, 2021 at 4:47 am
Defense Institute of Advanced Technology Start DIAT the registration process for DRDO Online Courses 2021 on Artificial Intelligence and Cyber Security. The registration process for both courses ...
- ArchIntel Releases ‘Competitive Artificial Intelligence: The Crossover Point’ White Paperon January 25, 2021 at 3:12 am
The full white paper is available for a free download on ArchIntel.com . “The Crossover Point” showcases the insights and highlights from a handful of senior executives in the field of competitive ...
- Artificial Intelligence in Healthcare Market 2021: Global Industry Manufacturers, Outlook, Share, Growth and Forecast 2027on January 24, 2021 at 11:07 pm
Jan (Heraldkeepers) -- Global Artificial Intelligence in Healthcare Industry Global Artificial Intelligence in Healthcare Market Report Outline ...
- Hearing aids now come with artificial intelligence. What does that mean?on January 24, 2021 at 10:04 pm
Premium hearing aids may use artificial intelligence like machine learning and deep neural networks to help process sound. Learn why this is a significant improvement for people with hearing loss.
- Fake News Is Rampant, Here Is How Artificial Intelligence Can Helpon January 24, 2021 at 9:25 pm
As with so many of our modern problems, artificial intelligence is now on the job helping to fight false news. Logically is one company that uses artificial intelligence to provide fact-checking ...
via Bing News